CCND3 and T-cell non-Hodgkin lymphoma: Interestingly, cyclin D3 and CDK4 are overexpressed in NOTCH-dependent T cell lymphomas, indicating that cell-cycle inhibitors and GSI should be used together to treat T cell lymphomas [76].